Loading...
Knight Therapeutics Inc.
GUD.TO•TSX
Healthcare
Drug Manufacturers - Specialty & Generic
CA$5.75
CA$0.00(0.00%)
Knight Therapeutics Inc. (GUD.TO) Financial Performance & Statements
Review Knight Therapeutics Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
13.13%
↑ 13.13%
Operating Income Growth
355.95%
↑ 355.95%
Net Income Growth
125.73%
↑ 125.73%
Operating Cash Flow Growth
0.95%
↑ 0.95%
Operating Margin
-0.21%
↓ 0.21%
Gross Margin
44.95%
↑ 44.95%
Net Profit Margin
2.97%
↑ 2.97%
ROE
1.42%
↑ 1.42%
ROIC
-0.09%
↓ 0.09%
Knight Therapeutics Inc. (GUD.TO) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Knight Therapeutics Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $96.86M | $92.26M | $95.57M | $86.60M |
| Cost of Revenue | $56.51M | $47.25M | $59.91M | $55.78M |
| Gross Profit | $40.35M | $45.02M | $35.66M | $30.83M |
| Gross Profit Ratio | $0.42 | $0.49 | $0.37 | $0.36 |
| R&D Expenses | $7.37M | $5.15M | $5.81M | $4.98M |
| SG&A Expenses | $25.32M | $25.48M | $25.36M | $23.19M |
| Operating Expenses | $43.31M | $41.81M | $31.17M | $28.17M |
| Total Costs & Expenses | $99.82M | $89.06M | $91.08M | $83.94M |
| Interest Income | $2.66M | $2.52M | $2.58M | $2.64M |
| Interest Expense | $2.45M | $1.92M | $2.28M | $2.58M |
| Depreciation & Amortization | $13.97M | $13.39M | $13.17M | $12.58M |
| EBITDA | $24.29M | $15.91M | $17.66M | $8.01M |
| EBITDA Ratio | $0.25 | $0.17 | $0.18 | $0.09 |
| Operating Income | -$2.96M | $3.20M | $4.49M | $2.66M |
| Operating Income Ratio | -$0.03 | $0.03 | $0.05 | $0.03 |
| Other Income/Expenses (Net) | $10.84M | -$2.60M | -$3.78M | -$9.80M |
| Income Before Tax | $7.88M | $608000.00 | $713000.00 | -$7.14M |
| Income Before Tax Ratio | $0.08 | $0.007 | $0.007 | -$0.08 |
| Income Tax Expense | -$2.86M | $523000.00 | $2.65M | -$2.60M |
| Net Income | $10.73M | $85000.00 | -$1.94M | -$4.55M |
| Net Income Ratio | $0.11 | $0.001 | -$0.02 | -$0.05 |
| EPS | $0.11 | $0.001 | -$0.02 | -$0.04 |
| Diluted EPS | $0.11 | $0.001 | -$0.02 | -$0.04 |
| Weighted Avg Shares Outstanding | $101.13M | $101.13M | $101.33M | $101.17M |
| Weighted Avg Shares Outstanding (Diluted) | $101.13M | $101.13M | $101.33M | $101.17M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan